Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L132758-5mg | 5mg | In stock | $177.90 | |
L132758-25mg | 25mg | In stock | $801.90 | |
L132758-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $2,883.90 |
Competitive melatonin receptor antagonist
Synonyms | luzindole|117946-91-5|N-Acetyl-2-benzyltryptamine|2-Benzyl-N-acetyltryptamine|N-[2-(2-benzyl-1H-indol-3-yl)ethyl]acetamide|N-Acetyl-2-benzyl-tryptamine|N 0774|N-0774|N-[2-[2-(Phenylmethyl)-1H-indol-3-yl]ethyl]acetamide|B31Y10A9UR|Acetamide, N-(2-(2-(pheny |
---|---|
Specifications & Purity | 96% |
Storage Temp | Store at -20°C |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of MT 1 receptor;Antagonist of MT 2 receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-[2-(2-benzyl-1H-indol-3-yl)ethyl]acetamide |
---|---|
INCHI | InChI=1S/C19H20N2O/c1-14(22)20-12-11-17-16-9-5-6-10-18(16)21-19(17)13-15-7-3-2-4-8-15/h2-10,21H,11-13H2,1H3,(H,20,22) |
InChi Key | WVVXBPKOIZGVNS-UHFFFAOYSA-N |
Canonical SMILES | CC(=O)NCCC1=C(NC2=CC=CC=C21)CC3=CC=CC=C3 |
Isomeric SMILES | CC(=O)NCCC1=C(NC2=CC=CC=C21)CC3=CC=CC=C3 |
PubChem CID | 122162 |
Molecular Weight | 292.37 |
PubChem CID | 122162 |
---|---|
ChEMBL Ligand | CHEMBL286615 |
Wikipedia | Luzindole |
CAS Registry No. | 117946-91-5 |
GPCRdb Ligand | luzindole |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
D2117235 | Certificate of Analysis | Feb 08, 2023 | L132758 |
D2117236 | Certificate of Analysis | Feb 08, 2023 | L132758 |
D2117239 | Certificate of Analysis | Feb 08, 2023 | L132758 |
Solubility | Soluble in DMSO (100 mM), ethanol (100 mM), chloroform, methanol, and water. |
---|---|
Sensitivity | heat sensitive |
Melt Point(°C) | 106 °C |
1. Jiang S et al.. (2021) Melatonin Ameliorates Axonal Hypomyelination of Periventricular White Matter by Transforming A1 to A2 Astrocyte via JAK2/STAT3 Pathway in Septic Neonatal Rats.. J Inflamm Res, 14 (5919-5937). [PMID:34803390] |
2. Zhou Q et al.. (2021) Melatonin Reduces Neuroinflammation and Improves Axonal Hypomyelination by Modulating M1/M2 Microglia Polarization via JAK2-STAT3-Telomerase Pathway in Postnatal Rats Exposed to Lipopolysaccharide.. Mol Neurobiol, 58 (12): (6552-6576). [PMID:34585328] |
3. Shuai Y et al.. (2016) Melatonin Treatment Improves Mesenchymal Stem Cells Therapy by Preserving Stemness during Long-term In Vitro Expansion.. Theranostics, 6 (11): (1899-917). [PMID:27570559] |